The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Rhode Island Prescription Drug Monitoring Program (PDMP).
The acronym for the Rhode Island PDMP is RI PDMP. It is administered by the Department of Health. The email address is provided, along with the URLs of the main website and related websites for enrollment and query. Contact information is provided for the PDMP Program Director and the PDMP Data Manager. In 2020, the state population was 1,098,163, and there were 7,050 DEA-registered prescribers and 188 DEA-registered dispensers. Eleven types of available PDMP report are listed. There are 11 members of the staff, who perform operational, technical, and analytical/epidemiological tasks. Dates are listed for the establishment and development of the PDMP. Information is provided for accessing laws and rules pertinent to the mission and policies of the PDMP. Nine miscellaneous capabilities and policies of the PDMP are listed. The data retention period is 5 years. There is no indication in this report that training is available or required for PDMP users. Enrollment procedures for a PDMP account are indicated. Law enforcement personnel’s access to PDMP patient data requires either a subpoena or a search warrant and a written request. PDMP enrollment is required for prescribers and dispensers; however, the use of the PDMP is required for only prescribers. Veterinarians have access to animal owner’s prescription history. Drug-related data monitored or accessible for the PDMP cover those listed on Schedules II-V, naloxone/narcan dispensing, and fatal overdoses. Technological capabilities of the PDMP are listed, along with requestors and reports authorized for production. No information is provided on the 2021 PDMP budget or funding sources.
810 Seventh Street NW, Washington, DC 20531, United States